Medicare Enrolled
Dr. Amro Balki, M.D.
Student in an Organized Health Care Education/Training Program · Santa Monica, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Balki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Balki?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Balki
Dr. Amro Balki is a student in an organized health care education/training program specialist in Santa Monica, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Balki performed 3,221 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Balki received a total of $238,037 from 66 pharmaceutical and/or device companies across 1927 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Balki is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 6% volume in CA
$238,037 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,221
Medicare services
Top 6% in CA for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Joint lubricant injection (Durolane) An injection of hyaluronan or its derivative, specifically Durolane, administered directly into a joint space. |
1,680 | $5 | $34 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
536 | $8 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $104 | $619 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
155 | $129 | $801 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
122 | $149 | $864 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $74 | $439 |
| Injection, methylprednisolone acetate, 40 mg | 86 | $6 | $36 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
72 | $62 | $362 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $83 | $542 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $12 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$238,037
Total received (2018-2024)
Avg $34,005/year across 7 years
Top 0% in CA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,927
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$106,021
2023
$26,299
2022
$19,366
2021
$10,146
2020
$16,798
2019
$30,375
2018
$29,032
Payments by company (2024)
Janssen Biotech, Inc.
$50,467
GENZYME CORPORATION
$21,272
Amgen Inc.
$12,137
ABBVIE INC.
$7,983
Novartis Pharmaceuticals Corporation
$6,023
SOBI, INC
$5,425
GlaxoSmithKline, LLC.
$383
Lilly USA, LLC
$270
UCB, Inc.
$267
Mallinckrodt Hospital Products Inc.
$195
E.R. Squibb & Sons, L.L.C.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$170
PFIZER INC.
$167
Radius Health, Inc.
$167
Aurinia Pharma U.S., Inc.
$125
Fidia Pharma USA Inc.
$103
AstraZeneca Pharmaceuticals LP
$83
Bioventus LLC
$79
Kiniksa Pharmaceuticals International, plc
$76
Alexion Pharmaceuticals, Inc.
$71
ANI Pharmaceuticals, Inc.
$71
SCILEX PHARMACEUTICALS INC.
$61
Fresenius Kabi USA, LLC
$52
Kyowa Kirin, Inc.
$48
Alvogen Inc
$32
Organon Llc
$28
Octapharma USA, Inc.
$25
IBSA Pharma Inc.
$24
Genentech USA, Inc.
$21
DePuy Synthes Sales Inc.
$20
Top 3 companies account for 79.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$59,758
Novartis Pharmaceuticals Corporation
$51,906
Amgen Inc.
$39,288
GENZYME CORPORATION
$28,270
ABBVIE INC.
$8,931
AstraZeneca Pharmaceuticals LP
$6,093
SOBI, INC
$5,439
UCB, Inc.
$5,386
Regeneron Pharmaceuticals, Inc.
$4,664
MEDEXUS PHARMA, INC.
$3,874
Horizon Therapeutics plc
$3,143
AbbVie Inc.
$2,764
Lilly USA, LLC
$2,133
Janssen Global Services, LLC
$2,000
PFIZER INC.
$1,875
AbbVie, Inc.
$1,764
GlaxoSmithKline, LLC.
$1,726
Boehringer Ingelheim Pharmaceuticals, Inc.
$936
Mallinckrodt Hospital Products Inc.
$795
Celgene Corporation
$698
MEDAC PHARMA, INC.
$661
DePuy Synthes Sales Inc.
$606
Radius Health, Inc.
$465
Horizon Pharma plc
$365
E.R. Squibb & Sons, L.L.C.
$363
Bioventus LLC
$305
Flexion Therapeutics, Inc.
$305
Janssen Scientific Affairs, LLC
$285
Antares Pharma, Inc.
$252
Alexion Pharmaceuticals, Inc.
$232
Hikma Pharmaceuticals USA
$204
Mallinckrodt Enterprises LLC
$195
Fresenius Kabi USA, LLC
$172
Kiniksa Pharmaceuticals, Ltd.
$161
Mallinckrodt LLC
$159
Takeda Pharmaceuticals U.S.A., Inc.
$133
Aurinia Pharma U.S., Inc.
$125
ANI Pharmaceuticals, Inc.
$123
NOVARTIS PHARMACEUTICALS CORPORATION
$122
Genentech USA, Inc.
$105
Fidia Pharma USA Inc.
$103
SANOFI-AVENTIS U.S. LLC
$99
Octapharma USA, Inc.
$96
West-Ward Pharmaceuticals
$90
Sobi, Inc
$81
Kiniksa Pharmaceuticals International, plc
$76
Teva Pharmaceuticals USA, Inc.
$70
SCILEX PHARMACEUTICALS INC.
$61
RedHill Biopharma Inc.
$60
Alvogen Inc
$60
Kyowa Kirin, Inc.
$48
Celltrion USA Inc.
$47
IBSA Pharma Inc.
$43
Exeltis, USA Inc.
$38
Vertiflex, Inc.
$36
Sandoz Inc.
$34
Zyla Life Sciences
$30
Organon Llc
$28
Pacira Pharmaceuticals Incorporated
$25
Sebela Pharmaceuticals Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Ultragenyx Pharmaceutical Inc.
$21
Gilead Sciences, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$18
Shionogi Inc
$12
Ferring Pharmaceuticals Inc.
$11
Top 3 companies account for 63.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUPIXENT · DUROLANE · Durolane · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · Exparel · FORTEO · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · MONOVISC · MOUNJARO · MOVANTIK · Mitigare · Movantik · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PANZYGA · PENNSAID · PREVNAR 13 · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · RAYOS · RELISTOR · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNAGIS · Strensiq · Superion ISS · Symproic · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tirosint · Trintellix · Tymlos · Uloric · XELJANZ · XYOSTED · YUFLYMA · ZORVOLEX · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
13,943
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
SANTA MONICA - UCLA MED CTR & ORTHOPAEDIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Balki is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Balki experienced with joint lubricant injection (durolane)?
Based on Medicare claims data, Dr. Balki performed 1,680 joint lubricant injection (durolane) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Balki receive payments from pharmaceutical companies?
Yes. Dr. Balki received a total of $238,037 from 66 companies across 1,927 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Balki's costs compare to other student in an organized health care education/training programs in Santa Monica?
Dr. Balki's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Balki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Santa Monica
Browse student in an organized health care education/training programs in Santa Monica ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in CA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in CA
Which CA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology